I learned via e-mail yesterday that the biotechnology program, that I taught with for ten years during the 90's, is ending due to low enrollments.
I also learned yesterday, via the Seattle Times
, that a resurrected version of ICOS called CMC Icos Biologics is planning a $35M expansion of their biotech manufacturing plant in Bothell and talking about hiring lots of students with two-year degrees.
The irony isn't lost on me.
We struggled with variable enrollments too, when I was at Seattle Central ... Read more